S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.05%) $0.926
USD/NOK
(-0.09%) $10.83
USD/GBP
(-0.10%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for Klaria Pharma Holding AB [KLAR.ST]

Exchange: STO Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated28 Mar 2024 @ 07:16

3.94% SEK 0.343

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:16):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy...

Stats
Today's Volume 166 631
Average Volume 220 004
Market Cap 36.53M
EPS SEK-0.101 ( 2023-11-24 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.700
ATR14 SEK0.0130 (3.79%)

Klaria Pharma Holding AB Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Klaria Pharma Holding AB Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK-9 000.00 (0.00 %)
EPS: SEK-0.360
Q4 2023
Revenue: SEK0
Gross Profit: SEK-3 000.00 (0.00 %)
EPS: SEK-0.0889
Q3 2023
Revenue: SEK619 000
Gross Profit: SEK619 000 (100.00 %)
EPS: SEK-0.100
Q2 2023
Revenue: SEK0
Gross Profit: SEK-2.76M (0.00 %)
EPS: SEK-0.0949

Financial Reports:

No articles found.

Klaria Pharma Holding AB

Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators